CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $746.16M, above the global median of $548.88M
- FinancialsAltman Z-Score 1.89: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.00BUSDvs all stocks (USD)
Trailing P/E
71.77xRevenue (TTM)
746.16MUSDvs all stocks (USD)
Profit Margin
1.96%Beta
0.2650xvs all stocks
52-Week Change
-0.87%vs all stocks
Market Capitalization
1.00BUSDvs all stocks (USD)
Enterprise Value
1.16BUSDvs all stocks (USD)
Trailing P/E
71.77xForward P/E
7.30xPEG Ratio
-0.3433xPrice to Sales (TTM)
1.34xPrice to Book (MRQ)
1.49xEnterprise to Revenue
1.56xEnterprise to EBITDA
9.38xGross Margin
77.05%Profit Margin
1.96%Operating Margin
6.17%Return on Assets (TTM)
1.48%Return on Equity (TTM)
2.05%Revenue (TTM)
746.16MUSDvs all stocks (USD)
Revenue per Share (TTM)
17.93USDUpdated Sep 28, 2026Quarterly Revenue Growth
6.20%Gross Profit (TTM)
591.01MUSDvs all stocks (USD)
EBITDA (TTM)
115.94MUSDvs all stocks (USD)
Net Income (TTM)
14.64MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.24%Operating Cash Flow (TTM)
187.66MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
98.34MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
726.41MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
149.75MUSDFY2025 · Dec 31, 2025Gross Profit
576.66MUSDFY2025 · Dec 31, 2025Operating Income
33.30MUSDvs all stocks (USD)
Pre-tax Income
16.87MUSDFY2025 · Dec 31, 2025Income Tax Expense
9.84MUSDFY2025 · Dec 31, 2025Net Income
7.03MUSDFY2025 · Dec 31, 2025EBIT
31.48MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
137.60MUSDFY2025 · Dec 31, 2025Research & Development
117.31MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
368.76MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
22.73MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
14.61MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.1600USDFY2025 · Dec 31, 2025EPS (Diluted)
0.1600USDFY2025 · Dec 31, 2025Basic Shares Outstanding
44.57MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
44.57MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
7.03MUSDFY2025 · Dec 31, 2025Operating Cash Flow
108.50MUSDFY2025 · Dec 31, 2025Free Cash Flow
93.17MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
158.54MUSDFY2025 · Dec 31, 2025Interest Paid
15.23MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
7.03MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
91.02MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
6.48MUSDFY2025 · Dec 31, 2025Stock-based Compensation
57.50MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-9.63MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-10.74MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-5.60MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-27.57MUSDFY2025 · Dec 31, 2025Capital Expenditures
-15.33MUSDFY2025 · Dec 31, 2025Net Acquisitions
-16.70MUSDFY2025 · Dec 31, 2025Purchase of Investments
-142.29MUSDFY2025 · Dec 31, 2025Sale of Investments
273.81MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
99.48MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
101.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-317.80MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-148.33MUSDFY2025 · Dec 31, 2025Other Financing Charges
-7.80MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-372.93MUSDFY2025 · Dec 31, 2025Shares Outstanding
39.82MSharesUpdated Sep 28, 2026Float Shares
36.19MSharesUpdated Sep 28, 2026Shares Short
7.56MSharesUpdated Sep 28, 2026Short Ratio
14.83daysvs all stocks
Short % of Shares Outstanding
27.27%vs all stocks
% Held by Insiders
1.74%vs all stocks
% Held by Institutions
113.30%vs all stocks
Total Cash (MRQ)
251.03MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
6.30USDUpdated Sep 28, 2026Total Debt (MRQ)
412.12MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6133xCurrent Ratio (MRQ)
5.04xBook Value per Share (MRQ)
16.87USDUpdated Sep 28, 2026Total Assets
1.26BUSDvs all stocks (USD)
Total Current Assets
547.97MUSDFY2025 · Dec 31, 2025Total Liabilities
571.81MUSDFY2025 · Dec 31, 2025Total Non-current Assets
716.94MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
451.22MUSDFY2025 · Dec 31, 2025Total Current Liabilities
120.59MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
158.54MUSDFY2025 · Dec 31, 2025Other Short-term Investments
79.88MUSDFY2025 · Dec 31, 2025Accounts Receivable
124.07MUSDFY2025 · Dec 31, 2025Inventory
152.86MUSDFY2025 · Dec 31, 2025Accounts Payable
15.15MUSDFY2025 · Dec 31, 2025Short-term Debt
9.84MUSDFY2025 · Dec 31, 2025Long-term Debt
408.37MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
38.64MUSDFY2025 · Dec 31, 2025Common Stock (Book)
48.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-199.32MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
693.11MUSDvs all stocks (USD)
Treasury Stock
176.56MUSDFY2025 · Dec 31, 202552-Week Low
18.80USDUpdated Sep 28, 202652-Week High
27.66USDUpdated Sep 28, 202652-Week Change
-0.87%vs all stocks
Beta
0.2650xvs all stocks
50-Day MA
25.31USDUpdated Sep 28, 2026200-Day MA
23.91USDUpdated Sep 28, 2026Avg 10-Day Volume
545.20KSharesUpdated Sep 28, 2026Avg 30-Day Volume
518.63KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
0.3500USDUpdated Sep 28, 2026Other Income / Expense
-21.71MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.77Profit Margin: 0.02
Financial Health
Altman Z-Score 1.89: grey zoneSignificant
Altman Z-Score: 1.89
High earnings qualityNotable
Earnings Quality Score: 1.82
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $746.16M, above the global median of $548.88MNotable
Revenue (USD): 746,163,968Global Median: 548,883,780.48
Levered free cash flow is $98.34M, above the global median of $18.73MNotable
Levered free cash flow (USD): 98,341,248Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Anhui Wanbang Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Kanghua Biological Products Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sino Medical Sciences Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sunflower Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Monte Rosa Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
0009K0
Tier 1ProductionApproval-Gated PipelineRuleRisk
Janux Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Haohai Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Blue Jet Healthcare Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Vor Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk